Anastasiya Lobachov

Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data

Elizabeth Dudnik, Mor Moskovitz, Yakir Rottenberg et al. · OncoImmunology · 2021 · 68 citations · Full text

Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung

Elizabeth Dudnik, Samuel A. Kareff, Mor Moskovitz et al. · Journal for ImmunoTherapy of Cancer · 2021 · 51 citations · Full text

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

Amin H. Nassar, So Yeon Kim, Jacqueline V. Aredo et al. · Journal of Thoracic Oncology · 2024 · 37 citations · Full text

Health Sciences, Medicine, Concurrent Chemoradiation +7

Real-world evidence for immunotherapy in the first line setting in small cell lung cancer

Shira Sagie, Nitzan Maixner, Amos Stemmer et al. · Lung Cancer · 2022 · 34 citations

Cancer Immunosurveillance, Medicine, First Line +11

Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancer

Sameh Daher, Alona Zer, Roi Tschernichovsky et al. · Lung Cancer · 2023 · 23 citations · Full text